Roche anticipates quicker U.S. approval for new MS drug

ZURICH, June 28 (Reuters) - Roche 's new multiple

sclerosis (MS) drug could be approved in the United States this

year, earlier than previously forecast, the Swiss drugmaker said

on Tuesday, after...

Read more